A Shareholder at McAndrews, Sanjay Murthy is a nationally recognized trial attorney who has been involved in more than 15 trials. He has deep experience representing leading life science and technology companies in federal district courts, before the Patent Trial and Appeal Board, and in Section 337 investigations in the U.S. International Trade Commission (ITC). In addition to an active litigation practice, he manages patent portfolios for several leading pharmaceutical and medical device companies. He also leverages his trial experience to assist his clients with EPO opposition proceedings, freedom-to-operate matters, due diligence investigations, patent portfolio audits, and licensing and collaboration transactions. For the last seven years, Sanjay has served on the faculty for Practicing Law Institute’s “Developments in Pharmaceutical and Biotech Patent Law” conference. He has also been invited to speak on IP-related ethics issues by the American Intellectual Property Law Association (AIPLA), Intellectual Property Owners (IPO), and the legal departments of multiple global companies.

Sanjay has been honored as a leading practitioner by a number of publications, including IAM Patent 1000, The Legal 500, Managing Intellectual Property, and Lawdragon. He’s also been recognized by The American Lawyer, LMG Life Sciences, and Crain’s Chicago Business for helping his clients secure significant trial victories.

Sanjay works with many technologies, such as pharmaceuticals (e.g., small molecules, antibodies, animal vaccines, and diagnostics), medical devices (e.g., implantable pulse generators, dialysis machines, drug infusion pumps, and stent grafts), methods for manufacturing recombinant proteins (e.g., Factor VIII and alpha-1 antitrypsin), cell-based therapeutics (CAR-T cells, tumor-infiltrating lymphocytes, and stem cells), organic/polymer chemistry, power tools, oil drilling fluids, digital cameras, smart phones, and automotive components.

Sanjay has an active pro bono practice. He has worked to reunite children separated from their parents by Immigration Customs Enforcement (ICE), force the release of numerous families detained by ICE in facilities threatened by COVID-19, and obtain significant monetary settlements for prisoners in civil rights cases.